PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 45 filers reported holding PIERIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $286 | +197.9% | 962,358 | +64.8% | 0.00% | – |
| Q2 2023 | $96 | -84.4% | 584,019 | -7.4% | 0.00% | -100.0% |
| Q1 2023 | $615 | -32.9% | 630,690 | -28.5% | 0.00% | -40.0% |
| Q4 2022 | $916 | -99.9% | 881,834 | +15.8% | 0.01% | 0.0% |
| Q3 2022 | $874,000 | -41.4% | 761,287 | -4.5% | 0.01% | -37.5% |
| Q2 2022 | $1,492,000 | +40.5% | 797,507 | +127.3% | 0.01% | +100.0% |
| Q1 2022 | $1,062,000 | -19.0% | 350,789 | +1.0% | 0.00% | -20.0% |
| Q4 2021 | $1,311,000 | +251.5% | 347,243 | +380.0% | 0.01% | +400.0% |
| Q3 2021 | $373,000 | -38.6% | 72,347 | -54.3% | 0.00% | -50.0% |
| Q2 2021 | $607,000 | -70.5% | 158,376 | -80.2% | 0.00% | -75.0% |
| Q1 2021 | $2,060,000 | -6.1% | 801,630 | -8.6% | 0.01% | 0.0% |
| Q4 2020 | $2,193,000 | +12.4% | 877,365 | -6.9% | 0.01% | 0.0% |
| Q3 2020 | $1,951,000 | -19.3% | 942,352 | +20.8% | 0.01% | -20.0% |
| Q2 2020 | $2,419,000 | +62.0% | 780,143 | +19.1% | 0.01% | +11.1% |
| Q1 2020 | $1,493,000 | -31.8% | 654,910 | +8.3% | 0.01% | -10.0% |
| Q4 2019 | $2,189,000 | -66.0% | 604,442 | -68.0% | 0.01% | -63.0% |
| Q3 2019 | $6,434,000 | -38.8% | 1,887,466 | -15.7% | 0.03% | -46.0% |
| Q2 2019 | $10,518,000 | +40.3% | 2,238,020 | 0.0% | 0.05% | +56.2% |
| Q1 2019 | $7,497,000 | +25.9% | 2,238,020 | 0.0% | 0.03% | +10.3% |
| Q4 2018 | $5,955,000 | -50.9% | 2,238,020 | +3.3% | 0.03% | -42.0% |
| Q3 2018 | $12,136,000 | +12.7% | 2,167,227 | +2.0% | 0.05% | +6.4% |
| Q2 2018 | $10,773,000 | +8.1% | 2,124,873 | +45.5% | 0.05% | +9.3% |
| Q1 2018 | $9,963,000 | +1036.0% | 1,460,841 | +1157.7% | 0.04% | +975.0% |
| Q4 2017 | $877,000 | +49.4% | 116,154 | +14.0% | 0.00% | +33.3% |
| Q3 2017 | $587,000 | +262.3% | 101,891 | +217.4% | 0.00% | +200.0% |
| Q2 2017 | $162,000 | – | 32,102 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 9,775,849 | $2,913,203 | 1.93% |
| Aquilo Capital Management, LLC | 3,303,190 | $984,351 | 0.89% |
| CM Management, LLC | 649,400 | $193,521 | 0.20% |
| BVF INC/IL | 20,609,863 | $6,141,739 | 0.17% |
| WEALTH EFFECTS LLC | 11,700 | $3,487 | 0.00% |
| NJ State Employees Deferred Compensation Plan | 30,000 | $8,940 | 0.00% |
| HUDSON VALLEY INVESTMENT ADVISORS INC /ADV | 14,000 | $4,172 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 962,358 | $286 | 0.00% |
| TWO SIGMA ADVISERS, LP | 24,400 | $7,271 | 0.00% |
| Tower View Wealth Management LLC | 1,000 | $0 | 0.00% |